medline.ch Onkologie Urologische Tumoren

	European Study of Prostate Cancer Screening - 23-Year Follow-up. N Engl J Med Thompson IM Jr. PMID: 41564407 [PubMed - in process]
	European Study of Prostate Cancer Screening - 23-Year Follow-up. N Engl J Med Raghavan D, Tannock IF. PMID: 41564406 [PubMed - in process]
	CT prostate angiogram for nerve-sparing robot-assisted radical prostatectomy. J Robot Surg Shanbhag A, Reisoglu S, Sabharwal T, Noël J. PMID: 41563651 [PubMed - indexed for MEDLINE]
	Retraction Note: Comment on: "Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study". World J Urol Aphale P, Dokania S, Shekhar H. PMID: 41563509 [PubMed - in process]
	A 24-Year Analysis of Percutaneous Renal Biopsy Trends in Australia. Med Sci (Basel) Sandhu K, Al-Khanaty A, Carll J, Murphy DG, Lawrentschuk N, Perera M. PMID: 41562909 [PubMed - indexed for MEDLINE]
	Fat quality, not quantity, linked to reduced risk of advanced and lethal prostate cancer in US populations: a large prospective multicenter study. Eur J Cancer Prev Li Y, Zhou M, Liao Y, Zhai Q, Zhang K, Huang X, Luo M, Lv S, Wei Q. PMID: 41562707 [PubMed - as supplied by publisher]
	Comment on "The role of adjuvant chemotherapy after radical surgery in patients with lymph node-positive bladder cancer or locally advanced (pT3, pT4a) bladder cancer: a meta-analysis and systematic review". Int J Surg Song S MSc, Yang W MSc, Gao C MD. PMID: 41562652 [PubMed - as supplied by publisher]
	Deferred Cytoreductive Nephrectomy in Unresectable/Metastatic Renal Cell Carcinoma: A Real-World Multicenter Retrospective Study. Int J Urol Tanaka R, Shinohara M, Kawashima Y, Sekine Y, Narita S, Kobayashi S, Abe N, Kodama H, Fujita N, Okamoto T, Yamamoto H, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S. PMID: 41562433 [PubMed - indexed for MEDLINE]
	Identification of prognostic biomarkers and development of a prediction model for prostate cancer. Front Immunol Chen D, Chen W, Ye R, Li L, Miao F, Kong X, Ning W, Jia J, Chen Q, Wang P, Yin B. PMID: 41562091 [PubMed - indexed for MEDLINE]
	Identify GDPD3 as a key regulator of epithelial-mesenchymal transition and prostate adenocarcinoma progression via the LPA/LPAR1/AKT axis: transcriptomic and experimental study. Front Immunol Hao L, Chen X, He T, Wu T, Wen Z, Ji Z, Zheng X, Zheng Q, Zhou Q, He C, Long Q, Sun D. PMID: 41562071 [PubMed - indexed for MEDLINE]
	Preoperative intravesical mitomycin C to reduce bladder recurrence in upper tract urothelial carcinoma - Insights from the landmark REBACARE trial. Indian J Urol Jain MP. PMID: 41562013 [PubMed]
	Toward a PSMA PET-mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trial. Front Oncol Celli M, Gunelli R, Ferroni F, Costantini M, Barone D, Fantini L, Fragalà E, Marini I, Di Iorio V, Foca F, Monti M, Matteucci F, Caroli P. PMID: 41561764 [PubMed]
	Association between the red cell distribution width-to-albumin ratio and recurrence-free survival and overall survival in patients with non-muscle-invasive bladder cancer: a retrospective cohort study. Front Oncol Song F, Su S, Zhang X, Cao Y, Cui X, Zhang L, Li C, Li S. PMID: 41561745 [PubMed]
	The predictive value of necroptosis-related lncRNAs in prostate cancer prognosis and their potential to distinguish between cold and hot tumors. Front Cell Dev Biol Zhang K, Li K, Deng J, Zhao C, Wang F, Xie J. PMID: 41561636 [PubMed]
	Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer-Introducing the Prospective "ProFam-Risk" Study. Eur Urol Open Sci Lakes J, Boschheidgen M, Antoch G, Klett MK, Karger A, Roth R, Redler S, Pai MG, Wieczorek D, Jäger B, Fehm TN, Niegisch G, Rau TT, Albers P. PMID: 41561489 [PubMed]
	Feasibility and Implementation of INTERVAL-GAP4: A Global Randomised Controlled Trial of Intense Hybrid-supervised/Self-managed Versus Self-directed Exercise for Metastatic Prostate Cancer. Eur Urol Open Sci Kenfield SA, Hart NH, Courneya KS, Greenwood R, Chan JM, Sison J, Zhang L, Rudman S, Ung L, Schumann M, Van Blarigan EL, McKeown S, Ryan CJ, Catto J, Galvão DA, Newton RU, Saad F, INTERVAL-GAP4 Site Investigators and INTERVAL-GAP4 Steering and Management Committees. PMID: 41561488 [PubMed]
	Circular RNA hsa_circ_0006168: A potential biomarker for the diagnosis and prognosis of prostate cancer. Oncol Lett Ding Y, Liu MT, Yu N, Gao L, Chen LP. PMID: 41560974 [PubMed]
	Killing cancer takes guts: lessons learned from the manipulation of gut microbiome and immunotherapy for the future of urothelial carcinoma. Oncoimmunology Reddy N, Lau K, Naman J, Lu K, McGillivary E, Salmasi A, Liss M, Stewart T. PMID: 41560593 [PubMed - indexed for MEDLINE]
	Hemangioblastoma of the Kidney-A Comprehensive Clinical, Pathological, and Genetic Analysis of Four Cases. APMIS Pósfai B, Jenei A, Forika G, Fintha A, Sápi Z, Somorácz Á, Dénes B, Salamon F, Eizler KV, Giba N, Semjén D, Illyés I, Kovács KA, Munkácsy G, Papp J, Sánta F, Butz H, Kuthi L. PMID: 41560567 [PubMed - indexed for MEDLINE]
	Conservative versus aggressive transurethral resection of bladder cancer for paraureteral bladder cancer: A comparison of postoperative ureteral stricture and cancer recurrence rates. Medicine (Baltimore) Fan D, Meng R, Han Y, Zhai Z. PMID: 41560099 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 175354

Seite 1 von 8768

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung